| Document |
Document Title |
|
WO/2021/030913A1 |
The present disclosure relates to cannabinoid compositions that are rehydratable and that upon such rehydration retain at least some of the properties of the original cannabinoid emulsions from which the cannabinoid composition was obtai...
|
|
WO/2021/032643A1 |
The present invention relates to a compound of the general formula I and the pharmaceutically acceptable salts thereof; where the variables are as defined in the claims and the description. The invention also relates to the compounds of ...
|
|
WO/2021/034089A1 |
The present invention relates to a compound for an organic electronic element, an organic electronic element using same, and an electronic device including the organic electronic element. According to the present invention, an organic el...
|
|
WO/2021/031622A1 |
Disclosed is a method for extracting and separating dihydromyricetin from Ampelopsis grossedentata tea, belonging to the technical field of natural medicine extraction and separation. The specific steps are as follows: 1) weighing Ampelo...
|
|
WO/2021/028810A1 |
The present invention relates to certain compounds, their use in therapy, as well as to pharmaceutical compositions including said compounds. Specifically, the invention relates to certain compounds and pharmaceutical compositions includ...
|
|
WO/2021/025162A1 |
A compound represented by formula (1) (wherein L1 and L2 are given linking groups and Ar1 is a monovalent group having a structure represented by formula (2)).
|
|
WO/2021/026257A1 |
Described herein are compounds and pharmaceutical compositions containing such compounds which are prodrugs of ALOX-15 inhibitors. Also described herein are methods for using such compounds in the treatment of disease.
|
|
WO/2021/025444A1 |
Despite various functions discovered of polyphenol-based compounds in regulating biological responses, such compounds, due to difficulty in procuring same in sufficient amounts with a high enough purity to permit application in pharmaceu...
|
|
WO/2021/025163A1 |
This organic electroluminescence element has a negative electrode, a positive electrode, and an organic layer between the negative electrode and the positive electrode, wherein the organic layer contains a compound represented by formula...
|
|
WO/2021/020481A1 |
The present invention is a method for producing an intermediate of iguratimod derivatives, a method for producing iguratimod, iguratimod having a novel crystal structure, and a method for producing the same. The present invention can rai...
|
|
WO/2021/021632A1 |
The present disclosure relates to the preparation of synthetic cannabinol and homologs thereof having the structure of Formula (I), wherein, n is 1, 2, 3 or 4. The methods described herein provide for high yields and purity in a one-pot ...
|
|
WO/2021/016717A1 |
The present disclosure relates to isolating one or more cannabinoids from an input mixture. There is disclosed an apparatus that comprises a mixing vessel, a volatizing unit, and a distillation unit. The mixing vessel combines a first in...
|
|
WO/2021/016720A1 |
The present technology generally relates to a triploid Cannabis plant, triploid Cannabis seeds and to methods for generating such triploid Cannabis plant. The methods comprise crossing a tetraploid Cannabis plant with a diploid Cannabis ...
|
|
WO/2021/018965A1 |
The present invention concerns compounds useful as modulators of sirtuins, in particular as SIRT1 activators. Moreover, the invention refers to the medical use of these compounds, in particular in the prevention and/or treatment of SIRT1...
|
|
WO/2021/016716A1 |
The present disclosure relates to isolating one or more cannabinoids from an input mixture. There is disclosed an apparatus that comprises a first reaction vessel, a volatizing unit, and a distillation unit. The first reaction vessel pro...
|
|
WO/2021/020788A2 |
The present invention relates to a method for synthesizing a 2-((6-(hydroxymethyl)chromene-5-yl)oxy)-1-phenylethanone derivative. When the method is used, a 2-((6-(hydroxymethyl)chromene-5-yl)oxy)-1-phenylethanone derivative can be effec...
|
|
WO/2021/016718A1 |
The present disclosure relates to isolating one or more cannabinoids from an input mixture. There is disclosed an apparatus that comprises a volatizing unit, a fractional distillation unit, and a condensing unit. The volatizing unit rece...
|
|
WO/2021/016280A1 |
The present disclosure provides certain tricyclic compounds that are Hypoxia Inducible Factor 2α (HIF-2α) inhibitors and are therefore useful for the treatment of diseases treatable by inhibition of HIF-2α. Also provided are pharmaceu...
|
|
WO/2021/014229A1 |
The present invention relates to a compound of formula (I) or an enantiomer, to a pharmaceutically acceptable salt or solvate of this compound, or to a mixture thereof, wherein the core A, the substituents Z, Y and R1i are as defined in ...
|
|
WO/2021/013931A1 |
The present invention relates to methods and means for inhibiting or preventing the growth of non-filamentous biofilm forming fungal cells with at least one flavone of formula (I) wherein R1, R2, R3, R4, R5, R6 and R7 are independently f...
|
|
WO/2021/013278A1 |
The invention relates to a process for preparing a coumarin-caged forskolin derivative, to the forskolin derivative as such and to the use of the forskolin derivative.
|
|
WO/2021/012046A1 |
There are provided compositions comprising at least one compound chosenfrom compound of formula (I), compound of formula (II), compound of formula (III) and compound of formula (IV) and a cannabinoid extract.
|
|
WO/2021/009026A1 |
Compounds of formula (I): (Formula (I)) Formula (I) encompasses e.g. tetraline, chromane, isochromane, 6,7,8,9-tetrahydrobenzo[7]annulene, 1H-isobenzofurane and indane derivatives. The compounds of formula (I) are useful as a pesticides,...
|
|
WO/2021/008170A1 |
The present application provides a flavone derivative, a preparation method therefor, an application thereof, and a skin whitening product comprising same. The flavone derivative is a compound having a structure represented by formula I ...
|
|
WO/2021/009229A1 |
The present invention relates to compounds of Formula (I), (I) wherein R1, R2, R3,W, Y, Z & G are as defined herein. The invention further relates to herbicidal compositions which comprise a compound of Formula (I), to their use for cont...
|
|
WO/2021/001128A1 |
The present invention relates to compounds that inhibit expression of Id1 and/or Id3, as well as uses thereof in the treatment of cancer and other diseases and conditions associated with Id1 and/or Id3 expression.
|
|
WO/2020/258014A1 |
Disclosed is a coumarin (ketone) oxime ester compound represented by formula (I) comprising the following formula (I-1) structural fragment, wherein X, A 1, A 2, A 3, A 4, R 3, R 4, R 5, R 6, R 8, R 9, R 10 and n are as defined in the sp...
|
|
WO/2020/261021A1 |
Described are polymerizable fused tricyclic compounds of formula I: wherein R1, R2, R3, m, n, t, and rings B, C, and D are as defined herein. The compounds absorb various wavelengths of ultraviolet and/or visible light (such as high ener...
|
|
WO/2020/262259A1 |
A method for peptide compound production which includes a step in which a compound represented by formula (1) is used; a reagent for protective-group formation which includes the compound; and the compound. At least one of R1 to R8 and Y...
|
|
WO/2020/263975A1 |
This disclosure provides multifunctional conjugate molecules in which at least one β-lactam antibiotic is covalently attached to a cannabinoid by means of a linker. The disclosed conjugate molecules are designed to deliver therapeutic b...
|
|
WO/2020/261299A1 |
The present invention relates to a cost-effective and eco-friendly technique of producing nuclear staining composition from Indian black berry fruit. The composition is as effective as its counterpart Hematoxylin in staining biological s...
|
|
WO/2020/259565A1 |
Disclosed is an industrializable method for rapidly and efficiently extracting xanthophyll and quercetagetin, comprising the following steps: 1) extracting particles of marigold flower with a solution of acetone having a volume fraction ...
|
|
WO/2020/261961A1 |
The present invention provides a chromene compound which can exhibit excellent photochromic properties. The chromene compound of the present invention is represented by formula (1). In the formula, at least one of R1 and R2 represents a ...
|
|
WO/2020/252588A1 |
Grafted cannabis plants and related methods for producing a grafted cannabis plant are provided. In some embodiments, a scion is provided from a first cannabis plant having at least one of a first desired phenotype and a first desired ge...
|
|
WO/2020/255156A1 |
The present invention relates to a compound of formula (I): or a pharmaceutically acceptable salt or a stereoisomer thereof, wherein X, R1, R2, R3, R4, R5, R6, m and n are as defined in the detailed description. The present invention als...
|
|
WO/2020/248060A1 |
Disclosed herein is a method for converting cannabidiol (CBD) into a composition comprising Δ9-tetrahydrocannabinol (Δ9-THC) and Δ8-tetrahydrocannabinol (Δ8-THC) in which the composition has a Δ9-ΤΗC:Δ8-ΤΗC ratio of greater tha...
|
|
WO/2020/248058A1 |
Disclosed herein a method for converting (cannabidiol) CBD into a composition comprising Δ8-tetrahydrocannabinol (A8-THC) and Δ9-tetrahydrocannabinol (Δ9-THC), in which the composition has a Δ8-THC:Δ9-THC ratio that is greater than ...
|
|
WO/2020/248057A1 |
Disclosed is a method for converting a first cannabinoid into a second cannabinoid that is a regioisomer of the first cannabinoid. The method comprises contacting the first cannabinoid with a Lewis-acidic heterogeneous reagent under reac...
|
|
WO/2020/248062A1 |
Disclosed herein is a method for converting a first cannabinoid into a composition comprising a second cannabinoid and a third cannabinoid, in which the second cannabinoid and the third cannabinoid are each isomers of the first cannabino...
|
|
WO/2020/248071A1 |
A method and system for isolating trichomes from plant matter. The method and system are applied to biomass including trichomes bound to structural plant material. The biomass is combined with a solution including a chelating agent for l...
|
|
WO/2020/248077A1 |
Disclosed are methods for separating, recovering, and purifying tetrahydrocannabinolic acid (THCA) salts from an organic solvent solution comprising a mixture of cannabinoids. The methods comprise solubilizing the mixture of cannabinoids...
|
|
WO/2020/248059A1 |
Disclosed is a method for converting a first cannabinoid into a second cannabinoid that is a regioisomer of the first cannabinoid. The method comprising contacting the first cannabinoid with: (i) a base having a pKb that is less than a c...
|
|
WO/2020/248923A1 |
Provided are a flavone derivative represented by formula I and a pharmaceutically acceptable salt, hydrate or solvate thereof. (I) In formula I, R1 is H, C1-4 alkyl, amino, or C1-4 acyl; R2 is isopentenyl or 2-hydroxy-isopentyl; R3 is H,...
|
|
WO/2020/248061A1 |
Disclosed herein is a method for converting cannabidiol (CBD) into a composition comprising Δ9-tetrahydrocannabinol ( Δ9-THC) and Δ8-tetrahydrocannabinol ( Δ8-THC) in which the composition has a Δ9-ΤΗΟ: Δ8-ΤΗΟ ratio of greate...
|
|
WO/2020/247599A1 |
1-Phenylacetyl-8-aminohexahydro-2H-pyrano[3,4-b]pyrazines of formula I are disclosed. The compounds are kappa ligands and are useful to treat drug dependency.
|
|
WO/2020/245142A1 |
A compound according to formula (-)-(Id*), wherein the compound shows negative specific rotation values, and it's use as fragrance.
|
|
WO/2020/243844A1 |
The present disclosure relates to a cannabinoid composition that has enhanced absorption rates or higher concentrations of the administered cannabinoid into the systemic circulation, the composition comprising at least one cannabinoid an...
|
|
WO/2020/240710A1 |
This flavonoid glycoside degradation method comprises: a hydrothermal treatment step for degrading flavonoid glycosides into flavonoids by performing, in an autoclave, a hydrothermal treatment on a raw material solution containing flavon...
|
|
WO/2020/241529A1 |
The present invention addresses the problem of providing a compound of high photobase generation efficiency. The present invention is a carbamoyl oxime compound represented by general formula (I). (In the formula, A represents an aroma...
|
|
WO/2020/240705A1 |
This flavonoid glycoside degradation method comprises: a hydrothermal treatment step for degrading flavonoid glycosides into flavonoids by performing, in an autoclave, a hydrothermal treatment on a raw material solution containing flavon...
|
